Karo Pharma AB (publ)
OTC: KARBF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Christoffer Lorenzen
- Employees
- 225
- Headquarters
- Stockholm, Sweden
- IPO year
- 2013
- Market cap
- $1.5B
- Website
- https://www.karopharma.com
Loading KARBF…
Loading profile data…Frequently asked questions about KARBF
What does Karo Pharma AB (publ) (KARBF) do?
Headquartered in Stockholm, Sweden, Karo Pharma AB (publ) specializes in the development and commercialization of both prescription pharmaceuticals and over-the-counter (OTC) health products. These offerings reach pharmacies and retail sectors across numerous global markets, including its home country of Sweden, the Nordic region (Norway, Denmar...
Where does KARBF trade?
Karo Pharma AB (publ) (KARBF) trades on the Other OTC.
What sector is KARBF in?
Karo Pharma AB (publ) (KARBF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Karo Pharma AB (publ)?
Christoffer Lorenzen is the chief executive officer of Karo Pharma AB (publ) (KARBF).
Where is Karo Pharma AB (publ) headquartered?
Karo Pharma AB (publ) is headquartered in Sweden.
Does KARBF pay a dividend?
Karo Pharma AB (publ) (KARBF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KARBF go public?
Karo Pharma AB (publ) (KARBF) completed its initial public offering in 2013.